Results 31 to 40 of about 315,901 (259)

Signaling mechanisms regulating Wallerian degeneration [PDF]

open access: yesCurrent Opinion in Neurobiology, 2014
Wallerian degeneration (WD) occurs after an axon is cut or crushed and entails the disintegration and clearance of the severed axon distal to the injury site. WD was initially thought to result from the passive wasting away of the distal axonal fragment, presumably because it lacked a nutrient supply from the cell body.
M. Freeman
semanticscholar   +5 more sources

Wallerian Degeneration Is Executed by an NMN-SARM1-Dependent Late Ca2+ Influx but Only Modestly Influenced by Mitochondria

open access: yesCell Reports, 2015
Axon injury leads to rapid depletion of NAD-biosynthetic enzyme NMNAT2 and high levels of its substrate, NMN. We proposed a key role for NMN in Wallerian degeneration but downstream events and their relationship to other mediators remain unclear.
Andrea Loreto   +3 more
doaj   +2 more sources

Wallerian degeneration in experimental focal cortical ischemia

open access: yesBrain Research Bulletin, 2019
Wallerian degeneration (WaD), commonly secondary to cerebral infarction, is the descending damage of fiber tracts with their accompanying myelin sheaths. However, whether this sequential injury can occur in non-ischemic corpus callosum (CC) and striatum in focal cortical ischemic model has not been fully demonstrated.
Meng Zuo   +9 more
semanticscholar   +3 more sources

The effects of claudin 14 during early Wallerian degeneration after sciatic nerve injury

open access: goldNeural Regeneration Research, 2014
Claudin 14 has been shown to promote nerve repair and regeneration in the early stages of Wallerian degeneration (0–4 days) in rats with sciatic nerve injury, but the mechanism underlying this process remains poorly understood.
Dengbing Yao   +6 more
openalex   +2 more sources

Neurodegeneration in multiple sclerosis

open access: yesWIREs Mechanisms of Disease, Volume 15, Issue 1, January/February 2023., 2023
Chronic demyelination results in impaired axon metabolism and function, ultimately leading to progressive neurological decline. Neuroprotective strategies aim to protect axons from inflammatory‐mediated destruction, thereby improving axonal integrity and clinical disability (Image created in BioRender.com).
Gabrielle M. Mey   +2 more
wiley   +1 more source

Home - About - Disclaimer - Privacy